Source: NS Medical Devices

EndoQuest: EndoQuest Robotics Accepted for Inclusion in FDA's Safer Technologies Program (STeP)

The post EndoQuest Robotics Accepted for Inclusion in FDA's Safer Technologies Program (STeP) appeared first on NS Medical Devices.

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

CEO

Kurt Azarbarzin

CEO Approval Rating

90/100

EndoQuest is a Texas-based medical device company that manufactures and markets robotic surgery systems for minimally invasive procedures.